Contracts › HHSO100201700029C
HHSO100201700029C: Igf::Ot::Igf - Base Period Award to Inbios International, Inc. for Point-Of-Care Immunoassay for Diagnosis of Inhalational Anthrax
Awarded to Inbios International Inc by Office of Assistant Secretary for Preparedness and Response.
$4.0Mobligated
$12.1Mpotential value
30 September 2027current end date
See modifications, all subcontractors and funding in FedSift →
| Contract | HHSO100201700029C |
|---|---|
| Awardee | Inbios International Inc |
| Awarding agency | Office of Assistant Secretary for Preparedness and Response |
| Awarding office | BARDA - ASPR / DAAPPO / BARDA DCMA |
| NAICS | 541711 Research and Development in Biotechnology |
| PSC | AN11 Health R&D Services; Health Care Services; Basic Research |
| Place of performance | WA |
| Offers received | 1 |
| Period of performance | 26 September 2017 to 30 September 2027 |
| Potential end | 30 September 2027 |
| Estimated recompete solicitation | ~Q2 2027 (estimate, ~6 months before expiry) |
Source: USASpending.gov (FPDS), public federal procurement data, as the agency reported it. Our record updated 03 October 2026. The solicitation date is an estimate from the end date, not a posted date.
Other expiring 541711 contracts · All expiring contracts · USASpending record